163 related articles for article (PubMed ID: 21486461)
1. Glucose lowering effect of transgenic human insulin-like growth factor-I from rice: in vitro and in vivo studies.
Cheung SC; Liu LZ; Lan LL; Liu QQ; Sun SS; Chan JC; Tong PC
BMC Biotechnol; 2011 Apr; 11():37. PubMed ID: 21486461
[TBL] [Abstract][Full Text] [Related]
2. Recombinant protein expression plasmids optimized for industrial E. coli fermentation and plant systems produce biologically active human insulin-like growth factor-1 in transgenic rice and tobacco plants.
Panahi M; Alli Z; Cheng X; Belbaraka L; Belgoudi J; Sardana R; Phipps J; Altosaar I
Transgenic Res; 2004 Jun; 13(3):245-59. PubMed ID: 15359602
[TBL] [Abstract][Full Text] [Related]
3. A biologically active rhIGF-1 fusion accumulated in transgenic rice seeds can reduce blood glucose in diabetic mice via oral delivery.
Xie T; Qiu Q; Zhang W; Ning T; Yang W; Zheng C; Wang C; Zhu Y; Yang D
Peptides; 2008 Nov; 29(11):1862-70. PubMed ID: 18708105
[TBL] [Abstract][Full Text] [Related]
4. Lab-scale Preparation of Recombinant Human Insulin-like Growth Factor-1 in
Mohamed OA; Samir S; Omar H; Hassan EA; Abdelazeem E
Recent Pat Biotechnol; 2022 Aug; 16(3):266-280. PubMed ID: 35418294
[TBL] [Abstract][Full Text] [Related]
5. A 90-day safety study of genetically modified rice expressing rhIGF-1 protein in C57BL/6J rats.
Tang M; Xie T; Cheng W; Qian L; Yang S; Yang D; Cui W; Li K
Transgenic Res; 2012 Jun; 21(3):499-510. PubMed ID: 21910016
[TBL] [Abstract][Full Text] [Related]
6. Reducing blood glucose level in TIDM mice by orally administering the silk glands of transgenic hIGF-I silkworms.
Cong L; Cao G; Renyu X; Zhonghua P; Xiaojian Z; Zhou W; Gong C
Biochem Biophys Res Commun; 2011 Jul; 410(4):721-5. PubMed ID: 21672515
[TBL] [Abstract][Full Text] [Related]
7. Biologically active human GM-CSF produced in the seeds of transgenic rice plants.
Sardana R; Dudani AK; Tackaberry E; Alli Z; Porter S; Rowlandson K; Ganz P; Altosaar I
Transgenic Res; 2007 Dec; 16(6):713-21. PubMed ID: 17985214
[TBL] [Abstract][Full Text] [Related]
8. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.
Kerr D; Tamborlane WV; Rife F; Sherwin RS
J Clin Invest; 1993 Jan; 91(1):141-7. PubMed ID: 8423214
[TBL] [Abstract][Full Text] [Related]
9. The correlation between expression and localization of a foreign gene product in rice endosperm.
Yasuda H; Hayashi Y; Jomori T; Takaiwa F
Plant Cell Physiol; 2006 Jun; 47(6):756-63. PubMed ID: 16614094
[TBL] [Abstract][Full Text] [Related]
10. Production of human growth hormone in transgenic rice seeds: co-introduction of RNA interference cassette for suppressing the gene expression of endogenous storage proteins.
Shigemitsu T; Ozaki S; Saito Y; Kuroda M; Morita S; Satoh S; Masumura T
Plant Cell Rep; 2012 Mar; 31(3):539-49. PubMed ID: 22108719
[TBL] [Abstract][Full Text] [Related]
11. Biological activity of human granulocyte-macrophage colony stimulating factor is maintained in a fusion with seed glutelin peptide.
Sardana RK; Alli Z; Dudani A; Tackaberry E; Panahi M; Narayanan M; Ganz P; Altosaar I
Transgenic Res; 2002 Oct; 11(5):521-31. PubMed ID: 12437083
[TBL] [Abstract][Full Text] [Related]
12. Human insulin-like growth factor I (IGF-I) produced in the mammary glands of transgenic rabbits: yield, receptor binding, mitogenic activity, and effects on IGF-binding proteins.
Wolf E; Jehle PM; Weber MM; Sauerwein H; Daxenberger A; Breier BH; Besenfelder U; Frenyo L; Brem G
Endocrinology; 1997 Jan; 138(1):307-13. PubMed ID: 8977418
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human MCF-7 breast cancer cells and HT-29 colon cancer cells by rice-produced recombinant human insulin-like growth binding protein-3 (rhIGFBP-3).
Cheung SC; Long X; Liu L; Liu Q; Lan L; Tong PC; Sun SS
PLoS One; 2013; 8(10):e77516. PubMed ID: 24143239
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
Camacho-Hübner C; Rose S; Preece MA; Sleevi M; Storr HL; Miraki-Moud F; Minuto F; Frystyk J; Rogol A; Allan G; Sommer A; Savage MO
J Clin Endocrinol Metab; 2006 Apr; 91(4):1246-53. PubMed ID: 16403822
[TBL] [Abstract][Full Text] [Related]
15. {alpha}' Subunit of soybean {beta}-conglycinin forms complex with rice glutelin via a disulphide bond in transgenic rice seeds.
Motoyama T; Maruyama N; Amari Y; Kobayashi K; Washida H; Higasa T; Takaiwa F; Utsumi S
J Exp Bot; 2009; 60(14):4015-27. PubMed ID: 19656819
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics of a continuous intravenous infusion of CGP-35126 recombinant human insulin-like growth factor-I (rhIGF-I) on glucose and insulin levels in healthy males.
Morgan JM; Piraino AJ; Saris SD; Capuzzi DM
Int J Clin Pharmacol Ther; 1994 May; 32(5):235-9. PubMed ID: 7921517
[TBL] [Abstract][Full Text] [Related]
17. Expression of biologically active human insulin-like growth factor 1 in Arabidopsis thaliana seeds via oleosin fusion technology.
Li W; Li L; Li K; Lin J; Sun X; Tang K
Biotechnol Appl Biochem; 2011 May; 58(3):139-46. PubMed ID: 21679237
[TBL] [Abstract][Full Text] [Related]
18. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus.
Crowne EC; Samra JS; Cheetham T; Watts A; Holly JM; Dunger DB
Metabolism; 1998 Jan; 47(1):31-8. PubMed ID: 9440474
[TBL] [Abstract][Full Text] [Related]
20. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes.
Lam XM; Duenas ET; Daugherty AL; Levin N; Cleland JL
J Control Release; 2000 Jul; 67(2-3):281-92. PubMed ID: 10825561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
